Importantly, no difference at the levels of PCSK9, LDLR, or their ratio was found when RA patients were compared with age-, gender,- and atheromatosis status-matched healthy controls (data not shown), implying that the RA disease per se does not have an impact on PCSK9 and LDLR levels. This evidence concerns the gene PCSK9 and rheumatoid arthritis.